Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control
- PMID: 22025782
- PMCID: PMC3198305
- DOI: 10.2337/dc11-0102
Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control
Abstract
Objective: To examine trends in microvascular complications in adolescents with type 1 diabetes between 1990 and 2009 in Sydney, Australia.
Research design and methods: We used analysis of complications in 1,604 adolescents (54% female, aged 12-20 years, median duration 8.6 years), stratified by four time periods using Generalized Estimation Equations as follows: T1 (1990-1994), T2 (1995-1999), T3 (2000-2004), and T4 (2005-2009). Early retinopathy was detected using seven-field fundal photography, albumin excretion rate (AER) using timed overnight urine collections, and albumin-to-creatinine ratio (ACR) and peripheral nerve function using thermal and vibration threshold.
Results: Retinopathy declined (53, 38, 23, and 12%; P < 0.001), as did borderline elevation of AER/ACR (45, 30, 26, and 30%; P < 0.001) and microalbuminuria (8, 4, 3, and 3%; P = 0.006). Multiple daily injections (MDI)/continuous subcutaneous insulin infusion (CSII) use increased (17, 54, 75, and 88%; P < 0.001), median HbA(1c) decreased (9.1, 8.9, 8.5, and 8.5%; P < 0.001), and severe hypoglycemia was unchanged (6, 8, 10, and 7%; P = 0.272). Retinopathy was associated with diabetes duration (odds ratio [OR] 1.12 [95% CI 1.08-1.17]), age (1.13 [1.06-1.20]), HbA(1c) (1.16 [1.08-1.25]), systolic blood pressure (BP) SDS (1.31 [1.16-1.48]), socioeconomic disadvantage (1.42 [1.04-1.95]), and 1 to 2 injections per day (vs. MDI/CSII; 1.35 [1.05-1.73]); borderline AER/ACR with male sex (1.32 [1.02-1.70]), age (1.19 [1.12-1.26]), HbA(1c) (1.18 [1.08-1.29]), weight SDS (1.31 [1.21-1.53]), insulin dose per kilograms (1.64 [1.13-2.39]), 1 to 2 injections per day (1.41 [1.08-1.84]), and socioeconomic disadvantage (1.68 [1.23-2.31]); and microalbuminuria with age (1.14 [1.01-1.29]), HbA(1c) (1.20 [1.05-1.37]), diastolic BP SDS (1.76 [1.26-2.46]), and 1 to 2 injections per day (1.95 [1.11-3.41]).
Conclusions: The decline in retinopathy supports contemporary guidelines that recommend lower glycemic targets and use of MDI/CSII in children and adolescents with type 1 diabetes.
Figures
Similar articles
-
Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.Diabetologia. 2021 Aug;64(8):1725-1736. doi: 10.1007/s00125-021-05456-w. Epub 2021 May 8. Diabetologia. 2021. PMID: 33966091 Free PMC article.
-
Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality.PLoS One. 2016 Apr 6;11(4):e0153033. doi: 10.1371/journal.pone.0153033. eCollection 2016. PLoS One. 2016. PMID: 27050468 Free PMC article.
-
Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.Diabet Med. 2008 Jul;25(7):765-74. doi: 10.1111/j.1464-5491.2008.02486.x. Diabet Med. 2008. PMID: 18644063 Review.
-
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20. Diabetologia. 2008. PMID: 18351320 Review.
-
Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002.Diabetes Care. 2005 Aug;28(8):1974-80. doi: 10.2337/diacare.28.8.1974. Diabetes Care. 2005. PMID: 16043741
Cited by
-
14. Children and Adolescents: Standards of Care in Diabetes-2024.Diabetes Care. 2024 Jan 1;47(Suppl 1):S258-S281. doi: 10.2337/dc24-S014. Diabetes Care. 2024. PMID: 38078582 Review.
-
Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.J Diabetes. 2024 Feb;16(2):e13486. doi: 10.1111/1753-0407.13486. Epub 2023 Oct 18. J Diabetes. 2024. PMID: 37853936 Free PMC article.
-
Screening of lipids and kidney function in children and adolescents with Type 1 Diabetes: does age matter?Front Endocrinol (Lausanne). 2023 Jun 2;14:1186913. doi: 10.3389/fendo.2023.1186913. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37334303 Free PMC article.
-
Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis.J Korean Med Sci. 2023 Jan 30;38(4):e24. doi: 10.3346/jkms.2023.38.e24. J Korean Med Sci. 2023. PMID: 36718561 Free PMC article.
-
14. Children and Adolescents: Standards of Care in Diabetes-2023.Diabetes Care. 2023 Jan 1;46(Suppl 1):S230-S253. doi: 10.2337/dc23-S014. Diabetes Care. 2023. PMID: 36507640 Free PMC article. Review.
References
-
- Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177–188 - PubMed
-
- Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol 1990;18:19–22 - PubMed
-
- Bonney M, Hing SJ, Fung AT, et al. Development and progression of diabetic retinopathy: adolescents at risk. Diabet Med 1995;12:967–973 - PubMed
-
- Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994;37:278–285 - PubMed
-
- Cook JJ, Daneman D. Microalbuminuria in adolescents with insulin-dependent diabetes mellitus. Am J Dis Child 1990;144:234–237 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous